US Stock MarketDetailed Quotes

VIVE Viveve Medical

Watchlist
  • 0.000300
  • 0.0000000.00%
15min DelayClose May 22 16:00 ET
3.22KMarket Cap0.00P/E (TTM)

Viveve Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-25.80%-3.35M
-22.30%-4.57M
-56.38%-5.09M
15.47%-12.88M
-40.43%-3.23M
3.06%-2.66M
16.12%-3.74M
43.29%-3.25M
51.23%-15.23M
57.24%-2.3M
Net income from continuing operations
15.06%-4.98M
-43.19%-5.8M
-1.64%-5.89M
-0.51%-22.03M
-33.08%-6.33M
-56.84%-5.86M
43.08%-4.05M
8.23%-5.79M
48.47%-21.92M
67.91%-4.76M
Operating gains losses
-98.44%1K
112.53%140K
-99.66%1K
-146.93%-872K
-2,016.67%-115K
357.14%64K
---1.12M
--296K
1,620.37%1.86M
-60.00%6K
Depreciation and amortization
-29.27%174K
-42.15%188K
-37.80%204K
-12.18%1.14M
-27.05%240K
-21.15%246K
-0.91%325K
0.00%328K
9.73%1.3M
-8.36%329K
Other non cash items
12.90%175K
-36.99%46K
29.82%283K
-6.10%862K
106.97%416K
-18.85%155K
-66.36%73K
-29.45%218K
-89.70%918K
-97.21%201K
Change In working capital
-75.72%395K
-453.15%-505K
-178.93%-648K
928.17%4.12M
31.47%1.53M
687.36%1.63M
126.83%143K
196.93%821K
78.73%-497K
259.13%1.16M
-Change in receivables
-143.11%-72K
24.48%-290K
-88.89%41K
-72.49%96K
72.00%-56K
-24.77%167K
-458.88%-384K
67.73%369K
-88.75%349K
-143.01%-200K
-Change in inventory
-81.51%105K
-90.63%43K
-108.33%-33K
62.28%2.21M
-30.43%784K
24.84%568K
185.79%459K
26.52%396K
227.10%1.36M
235.13%1.13M
-Change in prepaid assets
294.74%185K
-125.45%-14K
-233.60%-338K
-115.89%-24K
55.45%-237K
-160.51%-95K
-80.57%55K
4.12%253K
36.04%151K
-188.08%-532K
-Change in payables and accrued expense
-37.33%638K
-408.24%-432K
196.01%433K
136.58%1.15M
-1.76%670K
175.52%1.02M
82.40%-85K
77.45%-451K
19.71%-3.15M
-19.48%682K
-Change in other current assets
-220.14%-461K
2,188.89%188K
-25.33%112K
-30.59%320K
1,800.00%323K
-633.33%-144K
---9K
-64.03%150K
1,052.50%461K
--17K
-Change in other current liabilities
--0
--0
-929.81%-863K
10.27%365K
-37.88%41K
-46.19%113K
12.63%107K
360.00%104K
155.26%331K
108.70%66K
Cash from discontinued investing activities
Operating cash flow
-25.80%-3.35M
-22.30%-4.57M
-56.38%-5.09M
15.47%-12.88M
-40.43%-3.23M
3.06%-2.66M
16.12%-3.74M
43.29%-3.25M
51.23%-15.23M
57.24%-2.3M
Investing cash flow
Cash flow from continuing investing activities
-129.76%-193K
-942.86%-59K
42.35%-49K
41.61%-456K
22.22%-294K
24.32%-84K
105.34%7K
47.20%-85K
28.15%-781K
-58.16%-378K
Net PPE purchase and sale
-129.76%-193K
-942.86%-59K
42.35%-49K
41.61%-456K
22.22%-294K
24.32%-84K
105.34%7K
47.20%-85K
28.15%-781K
-58.16%-378K
Cash from discontinued investing activities
Investing cash flow
-129.76%-193K
-942.86%-59K
42.35%-49K
41.61%-456K
22.22%-294K
24.32%-84K
105.34%7K
47.20%-85K
28.15%-781K
-58.16%-378K
Financing cash flow
Cash flow from continuing financing activities
-9.52%19K
-98.07%13K
-99.92%19K
181.40%25.97M
1,900.00%18K
-99.41%21K
-83.35%673K
1,448.80%25.26M
-42.70%9.23M
-100.01%-1K
Net issuance payments of debt
----
----
----
--0
----
----
----
----
--1.34M
--0
Net common stock issuance
--0
--0
--0
7,473.61%25.83M
--0
--0
106.45%704K
--25.12M
-97.90%341K
--0
Proceeds from stock option exercised by employees
-9.52%19K
--13K
-89.39%19K
-97.42%217K
--17K
-99.42%21K
--0
-89.22%179K
14,912.50%8.41M
--0
Net other financing activities
----
----
----
91.87%-70K
200.00%1K
--0
96.03%-31K
-33.33%-40K
-287.84%-861K
99.15%-1K
Cash from discontinued financing activities
Financing cash flow
-9.52%19K
-98.07%13K
-99.92%19K
181.40%25.97M
1,900.00%18K
-99.41%21K
-83.35%673K
1,448.80%25.26M
-42.70%9.23M
-100.01%-1K
Net cash flow
Beginning cash position
-62.86%9.43M
-50.63%14.05M
193.76%19.16M
-50.98%6.52M
146.36%22.67M
198.72%25.39M
214.60%28.45M
-50.98%6.52M
-54.92%13.31M
1.25%9.2M
Current changes in cash
-29.27%-3.52M
-51.03%-4.61M
-123.34%-5.12M
286.28%12.64M
-30.86%-3.5M
-489.43%-2.73M
-463.65%-3.06M
613.90%21.92M
58.16%-6.79M
-163.41%-2.68M
End cash Position
-73.94%5.91M
-62.86%9.43M
-50.63%14.05M
193.76%19.16M
193.76%19.16M
146.36%22.67M
198.72%25.39M
214.60%28.45M
-50.98%6.52M
-50.98%6.52M
Free cash flow
-28.98%-3.54M
-24.11%-4.63M
-53.86%-5.14M
16.74%-13.33M
-31.58%-3.52M
3.88%-2.75M
18.67%-3.73M
43.39%-3.34M
50.45%-16.02M
52.32%-2.68M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -25.80%-3.35M-22.30%-4.57M-56.38%-5.09M15.47%-12.88M-40.43%-3.23M3.06%-2.66M16.12%-3.74M43.29%-3.25M51.23%-15.23M57.24%-2.3M
Net income from continuing operations 15.06%-4.98M-43.19%-5.8M-1.64%-5.89M-0.51%-22.03M-33.08%-6.33M-56.84%-5.86M43.08%-4.05M8.23%-5.79M48.47%-21.92M67.91%-4.76M
Operating gains losses -98.44%1K112.53%140K-99.66%1K-146.93%-872K-2,016.67%-115K357.14%64K---1.12M--296K1,620.37%1.86M-60.00%6K
Depreciation and amortization -29.27%174K-42.15%188K-37.80%204K-12.18%1.14M-27.05%240K-21.15%246K-0.91%325K0.00%328K9.73%1.3M-8.36%329K
Other non cash items 12.90%175K-36.99%46K29.82%283K-6.10%862K106.97%416K-18.85%155K-66.36%73K-29.45%218K-89.70%918K-97.21%201K
Change In working capital -75.72%395K-453.15%-505K-178.93%-648K928.17%4.12M31.47%1.53M687.36%1.63M126.83%143K196.93%821K78.73%-497K259.13%1.16M
-Change in receivables -143.11%-72K24.48%-290K-88.89%41K-72.49%96K72.00%-56K-24.77%167K-458.88%-384K67.73%369K-88.75%349K-143.01%-200K
-Change in inventory -81.51%105K-90.63%43K-108.33%-33K62.28%2.21M-30.43%784K24.84%568K185.79%459K26.52%396K227.10%1.36M235.13%1.13M
-Change in prepaid assets 294.74%185K-125.45%-14K-233.60%-338K-115.89%-24K55.45%-237K-160.51%-95K-80.57%55K4.12%253K36.04%151K-188.08%-532K
-Change in payables and accrued expense -37.33%638K-408.24%-432K196.01%433K136.58%1.15M-1.76%670K175.52%1.02M82.40%-85K77.45%-451K19.71%-3.15M-19.48%682K
-Change in other current assets -220.14%-461K2,188.89%188K-25.33%112K-30.59%320K1,800.00%323K-633.33%-144K---9K-64.03%150K1,052.50%461K--17K
-Change in other current liabilities --0--0-929.81%-863K10.27%365K-37.88%41K-46.19%113K12.63%107K360.00%104K155.26%331K108.70%66K
Cash from discontinued investing activities
Operating cash flow -25.80%-3.35M-22.30%-4.57M-56.38%-5.09M15.47%-12.88M-40.43%-3.23M3.06%-2.66M16.12%-3.74M43.29%-3.25M51.23%-15.23M57.24%-2.3M
Investing cash flow
Cash flow from continuing investing activities -129.76%-193K-942.86%-59K42.35%-49K41.61%-456K22.22%-294K24.32%-84K105.34%7K47.20%-85K28.15%-781K-58.16%-378K
Net PPE purchase and sale -129.76%-193K-942.86%-59K42.35%-49K41.61%-456K22.22%-294K24.32%-84K105.34%7K47.20%-85K28.15%-781K-58.16%-378K
Cash from discontinued investing activities
Investing cash flow -129.76%-193K-942.86%-59K42.35%-49K41.61%-456K22.22%-294K24.32%-84K105.34%7K47.20%-85K28.15%-781K-58.16%-378K
Financing cash flow
Cash flow from continuing financing activities -9.52%19K-98.07%13K-99.92%19K181.40%25.97M1,900.00%18K-99.41%21K-83.35%673K1,448.80%25.26M-42.70%9.23M-100.01%-1K
Net issuance payments of debt --------------0------------------1.34M--0
Net common stock issuance --0--0--07,473.61%25.83M--0--0106.45%704K--25.12M-97.90%341K--0
Proceeds from stock option exercised by employees -9.52%19K--13K-89.39%19K-97.42%217K--17K-99.42%21K--0-89.22%179K14,912.50%8.41M--0
Net other financing activities ------------91.87%-70K200.00%1K--096.03%-31K-33.33%-40K-287.84%-861K99.15%-1K
Cash from discontinued financing activities
Financing cash flow -9.52%19K-98.07%13K-99.92%19K181.40%25.97M1,900.00%18K-99.41%21K-83.35%673K1,448.80%25.26M-42.70%9.23M-100.01%-1K
Net cash flow
Beginning cash position -62.86%9.43M-50.63%14.05M193.76%19.16M-50.98%6.52M146.36%22.67M198.72%25.39M214.60%28.45M-50.98%6.52M-54.92%13.31M1.25%9.2M
Current changes in cash -29.27%-3.52M-51.03%-4.61M-123.34%-5.12M286.28%12.64M-30.86%-3.5M-489.43%-2.73M-463.65%-3.06M613.90%21.92M58.16%-6.79M-163.41%-2.68M
End cash Position -73.94%5.91M-62.86%9.43M-50.63%14.05M193.76%19.16M193.76%19.16M146.36%22.67M198.72%25.39M214.60%28.45M-50.98%6.52M-50.98%6.52M
Free cash flow -28.98%-3.54M-24.11%-4.63M-53.86%-5.14M16.74%-13.33M-31.58%-3.52M3.88%-2.75M18.67%-3.73M43.39%-3.34M50.45%-16.02M52.32%-2.68M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg